282 related articles for article (PubMed ID: 28154282)
1. The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet.
Shimizu R; Ohwada C; Nagao Y; Togasaki E; Kawajiri C; Muto T; Tsukamoto S; Sakai S; Takeda Y; Mimura N; Takeuchi M; Sakaida E; Iseki T; Nakaseko C
Intern Med; 2017; 56(3):353-356. PubMed ID: 28154282
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment with foscarnet for disseminated varicella-zoster infection after reduced intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma].
Aoyama Y; Yamamura R; Shima E; Nakamae H; Makita K; Hasegawa T; Sakamoto C; Terada Y; Kho G; Ohta K; Yamane T; Takubo T; Hino M
Rinsho Ketsueki; 2003 Jul; 44(7):451-5. PubMed ID: 12931563
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
Int J Infect Dis; 2014 Feb; 19():26-32. PubMed ID: 24211377
[TBL] [Abstract][Full Text] [Related]
4. Visceral varicella zoster virus infection after allogeneic stem cell transplantation.
Doki N; Miyawaki S; Tanaka M; Kudo D; Wake A; Oshima K; Fujita H; Uehara T; Hyo R; Mori T; Takahashi S; Okamoto S; Sakamaki H;
Transpl Infect Dis; 2013 Jun; 15(3):314-8. PubMed ID: 23551634
[TBL] [Abstract][Full Text] [Related]
5. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y
Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
[TBL] [Abstract][Full Text] [Related]
6. Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
Mullane KM; Nuss C; Ridgeway J; Prichard MN; Hartline CB; Theusch J; Mommeja-Marin H; Larson RA
Transpl Infect Dis; 2016 Oct; 18(5):785-790. PubMed ID: 27481400
[TBL] [Abstract][Full Text] [Related]
7. Low-dose acyclovir for prophylaxis of varicella-zoster virus reactivation after hematopoietic stem cell transplantation in children.
Tatebe Y; Ushio S; Esumi S; Sada H; Ochi M; Tamefusa K; Ishida H; Fujiwara K; Kanamitsu K; Washio K; Katsube R; Murakawa K; Zamami Y
Pediatr Blood Cancer; 2022 Dec; 69(12):e29979. PubMed ID: 36151963
[TBL] [Abstract][Full Text] [Related]
8. Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation.
Suzuki J; Ashizawa M; Okuda S; Wada H; Sakamoto K; Terasako K; Sato M; Kimura SI; Kikuchi M; Nakasone H; Kako S; Yamazaki R; Oshima K; Nishida J; Kanda Y
Transpl Infect Dis; 2012 Aug; 14(4):E7-12. PubMed ID: 22340704
[TBL] [Abstract][Full Text] [Related]
9. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
Asano-Mori Y; Kanda Y; Oshima K; Kako S; Shinohara A; Nakasone H; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
[TBL] [Abstract][Full Text] [Related]
10. Visceral varicella zoster virus (VZV) after allogeneic hematopoietic stem cell transplant (HSCT) in pediatric patients with chronic graft-versus-host disease (cGVHD).
Peritz DC; Duncan C; Kurek K; Perez-Atayde AR; Lehmann LE
J Pediatr Hematol Oncol; 2008 Dec; 30(12):931-4. PubMed ID: 19131784
[TBL] [Abstract][Full Text] [Related]
11. Varicella-Zoster Virus Reactivation After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation, Single-Center Experience of Acyclovir Prophylaxis.
Arıcı G; Ince E; Ince E; Ileri T; Ciftci E; Dogu F; Ozdemir H; Cakmakli HF; Ertem M
Pediatr Transplant; 2024 Aug; 28(5):e14819. PubMed ID: 38924278
[TBL] [Abstract][Full Text] [Related]
12. Late-onset visceral varicella-zoster virus infection presented as acute liver failure after allogeneic hematopoietic stem cell transplantation.
Kikuchi T; Arai M; Koda Y; Kato J; Shimizu T; Katano H; Fujii-Nishimura Y; Sakamoto M; Ebinuma H; Nakamoto N; Kanai T; Okamoto S; Mori T
Transpl Infect Dis; 2019 Aug; 21(4):e13121. PubMed ID: 31127967
[TBL] [Abstract][Full Text] [Related]
13. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
[TBL] [Abstract][Full Text] [Related]
14. A Rare Case of an Immunocompetent Male With Zoster Meningitis.
Faluk MA; Makadia S; Abdelmaseih R; Hasan SM; Abusaada K
J Investig Med High Impact Case Rep; 2020; 8():2324709620952212. PubMed ID: 32830563
[TBL] [Abstract][Full Text] [Related]
15. Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system.
Iten A; Chatelard P; Vuadens P; Miklossy J; Meuli R; Sahli R; Meylan PR
J Neurovirol; 1999 Apr; 5(2):172-80. PubMed ID: 10321981
[TBL] [Abstract][Full Text] [Related]
16. Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient.
Tauro S; Toh V; Osman H; Mahendra P
Bone Marrow Transplant; 2000 Oct; 26(7):795-6. PubMed ID: 11042663
[TBL] [Abstract][Full Text] [Related]
17. Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy.
Rau R; Fitzhugh CD; Baird K; Cortez KJ; Li L; Fischer SH; Cowen EW; Balow JE; Walsh TJ; Cohen JI; Wayne AS
Pediatr Infect Dis J; 2008 Mar; 27(3):265-8. PubMed ID: 18277922
[TBL] [Abstract][Full Text] [Related]
18. [Varicella-zoster virus infection after hematopoietic stem cell transplantation].
Akiyama H; Inoue T; Okoshi Y; Mori S; Ohashi K; Maeda Y; Sasaki T; Okuyama Y; Hiruma K; Sakamaki H
Rinsho Ketsueki; 2000 Jan; 41(1):20-4. PubMed ID: 10695394
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.
Umezawa Y; Kakihana K; Oshikawa G; Kobayashi T; Doki N; Sakamaki H; Ohashi K
Transpl Infect Dis; 2014 Apr; 16(2):195-202. PubMed ID: 24438510
[TBL] [Abstract][Full Text] [Related]
20. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]